Vaccine Response in Patients With Multiple Sclerosis Receiving Teriflunomide.
Front Neurol. 2022 Feb 28;13:828616. doi: 10.3389/fneur.2022.828616. eCollection 2022.
Front Neurol. 2022.
PMID: 35295832
Free PMC article.
Review.